Thursday, May 26, 2022
Outlook.com

Drugs Controller General Of India Dcgi

Covid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: Reports

Covid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: Reports

Bharat Biotech's Covaxin cleared for 6-12 age group by drugs regulator DCGI, as per media reports

26 April 2022
Govt Panel Recommends EUA For Covid Vaccine Covovax For 12-17 Age Group

Govt Panel Recommends EUA For Covid Vaccine Covovax For 12-17 Age Group

Director-Government and Regulatory Affairs at Serum Institute of India (SII) Prakash Kumar Singh had submitted an application to the DCGI on February 21,...

04 March 2022

Bharat Biotech's Intranasal Booster Dose Gets DCGI's Approval For Phase-3 Trials

DCGI on January 27 allowed Bharat Biotech to conduct phase-3 randomised multi-centric clinical study to evaluate immunogenecity and safety of its intranasal...

DCGI Grants Regular Market Approval For Covishield, Covaxin

DCGI Grants Regular Market Approval For Covishield, Covaxin

DCGI's  approval came after the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting...

27 January 2022

Need to hold vaccination on war footing, says MP CM Chouhan as inoculation drive for children begins

Chouhan also sought the participation of the elected representatives, volunteers and religious leaders to encourage children to get vaccinated. The vaccination...

Advertisement
28 December 2021
Biological E Aims To Produce 100 Mn Doses/Month Of Corbevax From Feb 2022

Biological E Aims To Produce 100 Mn Doses/Month Of Corbevax From Feb 2022

Corbevax has completed two Phase III clinical trials involving more than 3000 subjects between the ages of 18 and 80 at 33 study sites across India.


28 December 2021
CDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine Covovax

CDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine Covovax

The government had recently permitted the export of 2 crore doses of COVID-19 vaccine Covovax to Indonesia produced in India by SII, as the jab had not yet...


28 December 2021
Covovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SII

Covovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SII

The Covovax/Novavax vaccine has recently received Emergency Use Listing (EUL) with the World Health Organisation (WHO), Emergency Use Authorization (EUA) in...


19 December 2021
PM Calls Retired Lt Gen Hooda, Assures That His Ailing Sister's Request On New Breast Cancer Drug Will Be Considered

PM Calls Retired Lt Gen Hooda, Assures That His Ailing Sister's Request On New Breast Cancer Drug Will Be Considered

On Saturday afternoon, Sushma Hooda tweeted that she is requesting the prime minister "with great hope" to intervene and ensure early approval and purchase of...


03 September 2021
Biological E's Corbevax Gets DCGI Approval For Phase 2/3 Clinical Trial  On Children, Adolescents

Biological E's Corbevax Gets DCGI Approval For Phase 2/3 Clinical Trial On Children, Adolescents

Mahima Datla, Managing Director, Biological E. Limited, said these approvals would help support its subsequent filings with the World Health Organization (WHO)...


Advertisement

21 August 2021
Zydus Group Likely To Begin Supply Of  ZyCoV-D Vaccine By Mid To End September

Zydus Group Likely To Begin Supply Of ZyCoV-D Vaccine By Mid To End September

The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on...


21 August 2021
First Covid Vaccine For Children Above 12 Years By Zydus Cadila Gets Approval

First Covid Vaccine For Children Above 12 Years By Zydus Cadila Gets Approval

Previously, India's central drug authority's expert panel sent recommendations for the vaccine's EUA to the Drugs Controller General of India (DCGI) for final...


Advertisement
Advertisement
Advertisement
Advertisement